10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
36.75
+1.02 (2.85%)
At close: Jun 26, 2026, 4:00 PM EDT
36.85
+0.10 (0.27%)
After-hours: Jun 26, 2026, 7:54 PM EDT
10x Genomics Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for 10x Genomics stock have an average target of 24.73, with a low estimate of 20 and a high estimate of 40. The average target predicts a decrease of -32.71% from the current stock price of 36.75.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for 10x Genomics stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 12 | 12 | 10 | 10 | 10 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Reiterates $30 → $40 | Buy | Reiterates | $30 → $40 | +8.84% | Jun 24, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $32 | Buy | Reiterates | $32 | -12.93% | Jun 10, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 14, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $20 → $22 | Hold | Maintains | $20 → $22 | -40.14% | May 12, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $17 → $20 | Hold | Maintains | $17 → $20 | -45.58% | May 12, 2026 |
Financial Forecast
Revenue This Year
613.80M
from 642.82M
Decreased by -4.51%
Revenue Next Year
669.25M
from 613.80M
Increased by 9.03%
EPS This Year
n/a
from 0.12
Decreased by -100.00%
EPS Next Year
0.20
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 623.2M | 706.9M | |
| Avg | 613.8M | 669.2M | |
| Low | 605.5M | 641.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.1% | 15.2% | |
| Avg | -4.5% | 9.0% | |
| Low | -5.8% | 4.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.06 | 0.39 | |
| Avg | - | 0.20 | |
| Low | -0.06 | -0.02 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -51.3% | - | |
| Avg | -100.0% | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.